Dose Banded and Patient Specific Doses of Systemic Anti-Cancer Treatments (SACT)

Barts Health NHS TrustcontractContracts FinderRef LPPBARTS001-DN406495-99105398complete
View buyer

Estimated value

£6.0m

Awarded value

£6.0m

Awarded 10 Jun 2019

Suppliers

1

Lots

1

1 awarded

Published

11 Jun 2019

Deadline 09 Jun 2019

Description

The Trust is the cancer centre for North East London and provides a medical and haematological oncology service including bone marrow transplantation. The chemotherapy pharmacy department has a licensed chemotherapy production unit, providing over 45,000 doses of systemic anti-cancer treatments (SACT) per year. Demand for the provision of SACT has been rising consistently year on year. As such the department has developed a strategy to meet this demand and ensure that patient treatment requirements can be met. This strategy includes maximising efficiency of our existing production capacity by outsourcing doses that can be manufactured externally, to quality standards and that will be safe for the patient. The outsourced doses will be purchased in the form of both readymade dose banded products and patient specific doses.

Scope

Reference
LPPBARTS001-DN406495-99105398
Total value
£6,000,000 excluding VAT
Commercial tool
Standalone contract
Contract dates
31 Aug 2019 to 30 Aug 2024
CPV classifications
85149000

Submission & procedure

Submission deadline
09 Jun 2019, 11:00 pm

Award details

Awarded supplier(s), contract period and value as published in the award notice.

Awarded value

£6.0m

Award date

10 Jun 2019

Contract start

31 Aug 2019

Contract end

30 Aug 2024

Awarded to